Our data were consistent with previous studies reporting FMNL1 was overexpressed in glioblastoma, lung cancer and nasopharyngeal carcinoma, and was associated with patient prognosis (9–11). The gene discussed is FMNL1; the disease is nasopharyngeal carcinoma.